| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.087 | 0.03 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.03 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |